Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Alxn2060's trials
A Phase 3 Study of ALXN2060 in Japanese Participants With Symptomatic ATTR-CM
ALXN2060
Completed
Completed
Phase 3
Open NCT04622046 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
NCT04622046 · Trial Tracker · ComplyRx
